Skip to main content

The Role of CCK and CCK Antagonists in Human Esophageal and Gastroduodenal Motility

  • Chapter
Cholecystokinin Antagonists in Gastroenterology

Abstract

The pancreas and the gallbladder are known as the principal target organs of cholecystokinin (CCK) in the gastrointestinal tract. However, CCK receptors are located throughout the entire gut, having been identified on smooth muscle cells of the esophagus, stomach, small intestine, and colon [1]. Therefore it is conceivable that CCK is also involved in physiological modulation of gastrointestinal motility.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Walsh JH (1987) Gastrointestinal hormones. In: Johnson LR (ed) Physiology of the gastrointestinal tract. Raven, New York, pp 181–253

    Google Scholar 

  2. Makovec F, Christe R, Bani M, Pacini MA, Setnikar I, Rovati LA (1985) New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity. Arzneimittelforschung 35:1048–1051

    PubMed  CAS  Google Scholar 

  3. Setnikar I, Bani M, Cereda R, Christé R, Makovec F, Pacini MA, Revel L (1987) Anticholecystokinin activities of loxiglumide. Arzneimittelforschung 37: 1168–1171

    PubMed  CAS  Google Scholar 

  4. Resin H, Stern DH, Sturdevant RAL, Isenberg JI (1973) Effect of the C-terminal octapeptide of cholecystokinin on lower esophageal sphincter pressure in man. Gastroenterology 64:946–949

    PubMed  CAS  Google Scholar 

  5. Sturdevant RAL, Kun T (1974) Interaction of pentagastrin and the octapeptide of cholecystokinin on the human lower esophageal sphincter. Gut 15:700–702

    Article  PubMed  CAS  Google Scholar 

  6. Fisher RS, DiMarino AJ, Cohen S (1975) Mechanism of cholecystokinin inhibition of lower esophageal sphincter pressure. Am J Physiol 228:1469–1473

    PubMed  CAS  Google Scholar 

  7. Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC (1981) Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology 80:327–333

    PubMed  CAS  Google Scholar 

  8. Nebel OT, Castell DO (1972) Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology 63:778–783

    PubMed  CAS  Google Scholar 

  9. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA (1985) Cholecystokinin bioactivity in human plasma: molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 75:1144–1152

    Article  PubMed  CAS  Google Scholar 

  10. Brazer SR, Borislow DS, Liddle RA (1990) Cholecystokinin is not a major hormonal regulator of lower esophageal sphincter pressure. Gastroenterology 99:641–645

    PubMed  CAS  Google Scholar 

  11. Katschinski M, Koppelberg T, Wank U, Adler G, Rovati LC, Arnold R (1990) CCK plays a role as a physiological regulator of human esophageal motility (Abstr). J Gastrointest Motil 2:148

    Google Scholar 

  12. Biancani P, Walsh JH, Behar J (1984) Vasoactive intestinal polypeptide: a neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest 73: 963–967

    Article  PubMed  CAS  Google Scholar 

  13. Biancani P, Beinfeld MC, Hillemeier C, Behar J (1989) Role of peptide histidine isoleucine in relaxation of cat lower esophageal sphincter. Gastroenterology 97:1083–1089

    PubMed  CAS  Google Scholar 

  14. Rattan S, Goyal RK (1986) Structure-activity relationship of subtypes of cholecystokinin receptors in the cat lower esophageal sphincter. Gastroenterology 90:94–102

    PubMed  CAS  Google Scholar 

  15. Behar J, Biancani P (1977) Effect of cholecystokinin-octapeptide on lower esophageal sphincter. Gastroenterology 73:57–61

    PubMed  CAS  Google Scholar 

  16. Aggestrup S, Uddman R, Jensen SL, Hakanson R, Sundler F, Schaffalitzky de Muckadell O, Emson P (1986) Regulatory peptides in lower esophageal sphincter of pig and man. Dig Dis Sci 31:1370–1375

    Article  PubMed  CAS  Google Scholar 

  17. Chey WY, Hitanant S, Hendricks J, Lorber SH (1970) Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man. Gastroenterology 58:820–827

    PubMed  CAS  Google Scholar 

  18. Valenzuela JE, Defilippi C (1981) Inhibition of gastric emptying in humans by secretin, the octapeptide of cholecystokinin, and intraduodenal fat. Gastroenterology 81:898–902

    PubMed  CAS  Google Scholar 

  19. Konturek SJ, Kwiecien N, Obtulowicz W, Kopp B, Oleksy J, Rovati L (1990) Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans. Digestion 45:1–8

    Article  PubMed  CAS  Google Scholar 

  20. Liddle RA, Morita ET, Conrad CK, Williams JA (1986) Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 77:992–996

    Article  PubMed  CAS  Google Scholar 

  21. Kleibeuker JH, Beekhuis H, Jansen JBMJ, Piers DA, Lamers CBHW (1988) Cholecystokinin is a physiological hormonal mediator of fat-inhibition of gastric emptying in man. Eur J Clin Inv 18:173–177

    CAS  Google Scholar 

  22. Liddle RA (1989) Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay. Gastroenterol Clin North Am 18: 135–756

    Google Scholar 

  23. Scarpignato C, Zimbaro G, Vitulo F, Bertaccini G (1981) Caerulein delays gastric emptying of solids in man. Arch Int Pharmacodyn Ther 249:98–105

    PubMed  CAS  Google Scholar 

  24. Hasler W, Bowling B, Owyang C (1989) Intraduodenal lipids induce pyloric contractions: role of cholecystokinin and the cholinergic and opiate pathways (Abstr). Gastroenterology 96:A200

    Google Scholar 

  25. Fraser R, Fone D, Horowitz M, Dent J (1990) Dose related stimulation of pyloric motility in humans by cholecystokinin octapeptide (Abstr). Gastroenterology 98:A351

    Google Scholar 

  26. Corazziari E, Ricci R, Biliotti D, Bontempo I, Pallotta N, Torsoli A (1990) Oral administration of CCK antagonist loxiglumide inhibits postprandial gallbladder contraction without affecting gastric emptying. Dig Dis Sci 35:50–54

    Article  PubMed  CAS  Google Scholar 

  27. Niederau C, Mecklenbeck W, Heindges T, Lüthen R (1990) CCK hemmt die Magenentleerung einer regulären Mahlzeit unter physiologischen Bedingungen beim Menschen nicht (Abstr). Z Gastroenterol 28:510

    Google Scholar 

  28. Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, Morita ET (1989) Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans: implications for the physiology of CCK. J Clin Invest 84:1220–1225

    Article  PubMed  CAS  Google Scholar 

  29. Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JBMJ, Zach D, Rovati LC, Stalder GA (1989) Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 2:12–15

    Article  PubMed  CAS  Google Scholar 

  30. Green T, Dimaline R, Dockray GJ (1989) Neuroendocrine control mechanisms of gastric emptying in the rat. In: Singer MV, Goebell H (eds) Nerves and the gastrointestinal tract. MTP, Lancaster, pp 433–445

    Google Scholar 

  31. Moran T, Smith GP, Hostetler AM, McHugh PR (1987) Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res 415:149–152

    Article  PubMed  CAS  Google Scholar 

  32. Allescher HD, Daniel EE, Fox JET, Kostolanska F, Rovati LA (1989) Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo. J Pharmacol Exp Ther 251:1134–1141

    PubMed  CAS  Google Scholar 

  33. Telford GL, Mir SS, Mason GR, Ormsbee HS III (1979) Neural control of canine pylorus. Am J Surg 137:92–98

    Article  PubMed  CAS  Google Scholar 

  34. Kuwahara A, Ozawa K, Yanaihara N (1986) Effects of cholecystokinin-octapeptide on gastric motility of anesthetized dogs. Am J Physiol 251: G678–G681

    PubMed  CAS  Google Scholar 

  35. Vizi E, Bertaccini G, Implicciatore M, Knoll J (1973) Evidence that acetylcholine release by gastrin and related polypeptides contributes to their effect on gastrointestinal motility. Gastroenterology 64:268–277

    PubMed  CAS  Google Scholar 

  36. Scheurer UL, Varga L, Drack E, Burki HR, Halter F (1983) Mechanisms of action of CCK-octapeptide on rat antrum, pylorus, and duodenum. Am J Physiol 244:G266–G272

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Katschinski, M. (1991). The Role of CCK and CCK Antagonists in Human Esophageal and Gastroduodenal Motility. In: Adler, G., Beglinger, C. (eds) Cholecystokinin Antagonists in Gastroenterology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76362-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76362-5_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76364-9

  • Online ISBN: 978-3-642-76362-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics